TABLE OF CONTENTS
Volume 16, Issue 3 (March 2009)
Original Articles
Intravenous injection of siRNA directed against hypoxia-inducible factors prolongs survival in a Lewis lung carcinoma cancer model
F Kamlah, B G Eul, S Li, N Lang, L M Marsh, W Seeger, F Grimminger, F Rose and J Hänze
Cancer Gene Ther 16: 195-205; advance online publication, September 26, 2008; doi:10.1038/cgt.2008.71
MicroRNA profile analysis of human prostate cancers
A W Tong, P Fulgham, C Jay, P Chen, I Khalil, S Liu, N Senzer, A C Eklund, J Han and J Nemunaitis
Cancer Gene Ther 16: 206-216; advance online publication, October 24, 2008; doi:10.1038/cgt.2008.77
Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA
M Mikhaylova, I Stasinopoulos, Y Kato, D Artemov and Z M Bhujwalla
Cancer Gene Ther 16: 217-226; advance online publication, October 17, 2008; doi:10.1038/cgt.2008.79
Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo
X H Shi, Z Y Liang, X Y Ren and T H Liu
Cancer Gene Ther 16: 227-236; advance online publication, October 24, 2008; doi:10.1038/cgt.2008.82
The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells
T Katsura, S Iwai, Y Ota, H Shimizu, K Ikuta and Y Yura
Cancer Gene Ther 16: 237-245; advance online publication, October 24, 2008; doi:10.1038/cgt.2008.81
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation
L R McNally, E L Rosenthal, W Zhang and D J Buchsbaum
Cancer Gene Ther 16: 246-255; advance online publication, October 10, 2008; doi:10.1038/cgt.2008.76
Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity
Y Piao, H Jiang, R Alemany, V Krasnykh, F C Marini, J Xu, M M Alonso, C A Conrad, K D Aldape, C Gomez-Manzano and J Fueyo
Cancer Gene Ther 16: 256-265; advance online publication, October 17, 2008; doi:10.1038/cgt.2008.75
Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
J Altomonte, L Wu, M Meseck, L Chen, O Ebert, A Garcia-Sastre, J Fallon, J Mandeli and S L C Woo
Cancer Gene Ther 16: 266-278; advance online publication, October 10, 2008; doi:10.1038/cgt.2008.74
